Patient |
Age (years) |
Tumor type
and stage |
Radiation source |
Fraction number |
Total dose (Gy) |
| 1 |
47 |
vagina ca.
stage; IIB |
Co-60 THR |
25 |
50 |
| 2 |
51 |
Op. corpus ca.
stage; IC |
Co-60 THR |
25 |
50 |
| 3 |
49 |
Op. cervix ca.
stage; IC |
Co-60 THR |
25 |
50 |
| 4 |
74 |
Inop. cervix ca.
stage; IIB |
Co-60 THR |
25 |
50 |
| 5 |
74 |
Op. endo. ca.
stage; IIA |
Co-60 THR |
25 |
50 |
| 6 |
64 |
Op. endo. ca.
stage; IC |
Linac-18 MV |
25 |
50 |
| 7 |
43 |
Cervix ca
stage; IIB |
Co-60 THR |
25 |
50 |
| 8 |
56 |
Op. endo. ca.
stage; IIIA |
Co-60 THR |
25 |
50 |
| 9 |
58 |
Op. endo. ca.
stage; IIB |
Co-60 THR |
25 |
50 |
| 10 |
35 |
Op. endo. ca.
stage; IIB |
Co-60 THR |
25 |
50 |
| 11 |
73 |
Op. endo. ca.
stage; IC |
Co-60 THR |
25 |
50 |
| 12 |
45 |
recur. over ca.
stage; recur |
Co-60 THR |
25 |
50 |
| 13 |
71 |
Inop. cervix ca.
stage; IIB |
Co-60 THR |
25 |
50 |
| 14 |
54 |
Endo. ca.
stage; IIB |
Co-60 ATC |
25 |
50 |
| 15 |
55 |
Op. endo. ca.
stage; IIIA |
Co-60 THR |
25 |
50 |
| 16 |
69 |
Op. cervix ca.
stage; IB |
Co-60 THR |
25 |
50 |
| 17 |
43 |
endo. ca.
stage; IB |
Co-60 ATC |
25 |
50 |
| 18 |
54 |
Op. endo. ca.
stage; IIA |
Co-60 ATC |
25 |
50 |
| 19 |
82 |
Op. endo. ca.
stage; IC |
Co-60 THR |
25 |
50 |
| 20 |
49 |
Op. endo. ca.
stage; IC |
Linac 18-MV |
25 |
50 |
ca; carcinoma, Op; operated, Inop; inoperated, endo; endometrium, recur; recurrent |
